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HEALTHCAREPOLICYAND LAW
The Use of Public Health Evidence
inWholeWoman’s Health v Hellerstedt
Enacted in 2013,Texas’s HouseBill 2 (HB2)was one of
themost restrictiveabortion laws in thecountry.The law
had 4 provisions: (1) physicians providing abortion had
tohaveadmittingprivilegesatnearbyhospitals, (2)medi-
cationabortionhad tobeprovidedaccording to thepro-
tocol described in the US Food and Drug Administra-
tion (FDA)-approved labeling ofmifepristone, (3)most
abortions at 20 weeks postfertilization or later were
banned,and (4) facilitiesprovidingabortionhadtomeet
the standards of ambulatory surgical centers. The first
3 provisions went into effect by November 2013; the
fourth provision, meeting the standards of ambulatory
surgical centers, was enforced only briefly in October
2014 before the US Supreme Court issued a stay.
The most immediate impact of HB 2 was the clo-
sure of clinics—first because physicians could not ob-
tain or maintain admitting privileges, and in October
2014because theydidnotmeet thesurgical center stan-
dards. In April 2013, before the introduction of HB 2,
therewere41 facilitiesprovidingabortion inTexas;when
the ambulatory surgical center provisionwas enforced,
there were only 10 facilities serving a population of 5.4
million women of reproductive age.1,2
Several abortion providers challenged the admit-
ting privileges and the ambulatory surgical center pro-
visions of HB 2 in the case ofWhole Woman’s Health v
Hellerstedt, which was argued before the US Supreme
Court earlier this year. The Court ruled 5 to 3 that these
provisions were unconstitutional because they im-
posedanundueburdenonwomen’saccess toabortion.3
In particular, the Court weighed the evidence regard-
ing thepotential benefit ofHB2against theevidenceof
its harmand found the latter to bemore compelling. To
reach this conclusion, the Court relied on considerable
public health evidence, highlighting the important role
that clinical and social science research can play in in-
forming health policy.
Since 2011, I have collaborated with colleagues at
the University of Texas at Austin and other institutions
in the Texas Policy Evaluation Project, which aims to
study the impact of reproductive health legislation in
the state. In 2011, the legislature voted to cut public
funding for contraceptive services by two-thirds and
excluded providers affiliated with Planned Parenthood
from a state-funded replacement program for the Texas
Medicaid fee-for-service family planning program.
These changes effectively dismantled the state’s family
planning safety net and likely increased pregnancy
among low-income Texanwomen.4
Althoughthecontraceptivebudgetcutsclosedfam-
ily planning clinics in Texas, HB 2 closed abortion clin-
ics. On the day the admitting privileges provision went
into effect, 11 facilities closed because physicians had
been unable to obtain privileges.2 Obtaining andmain-
tainingprivilegeswasdifficult forabortionproviderswho
rarely—if ever—admit patients to a hospital.
The closure of facilities affectedwomen’s access in
2 ways. First, the closures reduced the geographic dis-
tributionof facilities, concentrating services in larger cit-
ies and increasingdistances to thenearest clinic. For ex-
ample, in April 2013, about 400 000 women of
reproductiveage inTexas livedmorethan100miles from
the nearest abortion clinic in the state.2 By May 2014,
thatnumberhad increasedtoapproximately 1 000000.
Second, as clinics closed, the reducedcapacityof the re-
maining facilities increased wait times to get an
appointment.5Forexample, inDallasandFortWorth, the
wait times had stabilized around 5 days by early 2015.
Whena large-volumeprovider thereclosed inJune2015,
thewait times at the remaining facilities increased to 21
days or longer.
To evaluate the impact of HB 2, it was critical to
document the changes in abortion service delivery af-
ter itwent intoeffect.Theusualwaytoperformthis type
of research is toanalyzeofficial abortionstatistics.How-
ever,becauseTexasreleasesthesedata2yearsafter they
are collected, it became clear we needed to collect the
data ourselves to inform this policy debate.
In early 2014,wecontacted the41 abortionprovid-
ers that were open at the end of 2012—including those
that subsequently closed—toobtain informationon the
services they provided through April 2014.2 We com-
pared the abortion numbers for the period November
2013 to April 2014—the first 6 months after HB 2 went
intoeffect—tothesameperiod1yearprior.Wefoundthat
the total number of abortions performed in Texas de-
clined by 13% (a reduction of about 9000 procedures
annually), which was a steeper drop than had been re-
ported in the state or nationally in recent years. Given
the cuts in familyplanning services that had takenplace
inTexas in theprecedingyears, itwashighlyunlikely that
this declinewas due to a reduction in unintended preg-
nancy. The official Texas statistics for 2014,whichwere
released 3 days after the Supreme Court ruling in June
2016, confirmedourearlierestimatesand indicated that
few women (<2% of Texas residents obtaining abor-
tion) traveled out of state for services.6
One of the most alarming findings of our research
was that therewasa small but significant increase in the
proportion of abortions performed after 12 weeks
gestation.2Theofficial statistics for2014 indicated there
was a 27% increase in second-trimester abortion com-
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paredwith 2013 (from4814 to 6117 procedures) after adjusting for
the fact that the state changed how gestational duration was re-
ported (from weeks since last menstrual period in 2013, to weeks
since fertilization in 2014).7 This increase in later abortion is a par-
ticular cause for concern from a public health perspective because
second-trimester abortion, although very safe, is associatedwith a
higher risk of complications, such as hemorrhage, compared with
first-trimester abortion.8 It is alsomore expensive for women, and
there are fewer physicians who perform second-trimester abor-
tions. Of note, the provisions of HB 2 banningmost abortions after
20 weeks and restricting medication abortion are still in effect, al-
though the latter is essentially moot since the FDA approved up-
dated labeling for mifepristone in March 2016. Before the labeling
change, however, there was a 70% reduction in medication abor-
tion statewide.2
To document the impact of clinic closures on women, we sur-
veyed abortion patients throughout the state in 2014.7 We com-
pared the experiences of women whose nearest clinic closed be-
tween 2013 and 2014 with those of women whose nearest clinic
remained open. We found that women whose nearest clinic had
closed traveled 4 times farther to obtain an abortion—85 miles on
average each way—compared with those whose nearest clinic re-
mainedopen. In addition,morewomenwhosenearest clinic closed
had out-of-pocket expenditures greater than $100 (32% vs 20%).
We also conducted in-depth interviews with 23 women af-
fectedbyHB2.3Wespokewithwomenwhowere turnedaway from
clinics that closedandheardhow it took timeandmoney to findan-
other open clinic and arrange transportation. For some, these ob-
stacles created delays that pushed them into the second trimester
before they could obtain care. A fewwomenwe interviewed were
unable to obtain the abortion they desired at all. They were forced
to continue the pregnancy because it was too logistically compli-
cated and expensive to travel to a more distant clinic.
In contrast to the harmswedocumentedofHB2, during the le-
gal proceedings Texas offered little evidence of benefit for the chal-
lengedprovisions. Instead, theSupremeCourtcitedtheevidencethat
abortion as currently practiced in the United States is exceedingly
safe—safer than continuing thepregnancy to termand safer thanor
similar tootheroutpatientprocedures, suchas colonoscopyorden-
tal orplastic surgery, that arenot similarly regulated.9Friend-of-the-
courtbriefs submittedby social scientists andbyprofessionalmedi-
cal groups, including the American College of Obstetricians and
Gynecologists and the AmericanMedical Association, cited numer-
ous peer-reviewed articles documenting the safety of abortion.
With regard to the ambulatory surgical center provision of HB
2,a recent systematic review10 foundthatmajorcomplications, such
asthoserequiringhospitalizationor transfusion,occurred in less than
0.5% of first-trimester abortions. These rates were similar among
studies performed in outpatient clinics, ambulatory surgical cen-
ters, orhospitals.10Our researchalso indicated that theexistingam-
bulatory surgical centers in Texas were unlikely to be able to meet
thedemand for services statewide if all the clinics thatwerenot am-
bulatory surgical centers closed.2
TheSupremeCourtdecision in theWholeWoman’sHealth case
provides a clearer judicial standard related to undue burden on
women seeking abortion. The Court said laws restricting abortion
cannot be considered in the abstract—or just because a legislature
says theywouldbebeneficial. Instead,courtsmustcomparetheben-
efit the law is likely to provide with the burden the lawwill impose
onwomen.TheCourt’sdecisionshowsthatevidencematters,which
hopefully heralds anewemphasis ondata-drivenpolicies for repro-
ductive health.
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